BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37694549)

  • 1. Genome-wide methylation profiling of diagnostic tumor specimens identified DNA methylation markers associated with metastasis among men with untreated localized prostate cancer.
    Chao CR; Slezak J; Siegmund K; Cannavale K; Shu YH; Chien GW; Chen XF; Shi F; Song N; Van Den Eeden SK; Huang J
    Cancer Med; 2023 Sep; 12(18):18837-18849. PubMed ID: 37694549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation markers for risk of metastasis in a cohort of men with localized prostate cancer.
    Habeshian TS; Cannavale KL; Slezak JM; Shu YH; Chien GW; Chen X; Shi F; Siegmund KD; Van Den Eeden SK; Huang J; Chao CR
    Epigenetics; 2024 Dec; 19(1):2308920. PubMed ID: 38525786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-Wide Measures of Peripheral Blood Dna Methylation and Prostate Cancer Risk in a Prospective Nested Case-Control Study.
    FitzGerald LM; Naeem H; Makalic E; Schmidt DF; Dowty JG; Joo JE; Jung CH; Bassett JK; Dugue PA; Chung J; Lonie A; Milne RL; Wong EM; Hopper JL; English DR; Severi G; Baglietto L; Pedersen J; Giles GG; Southey MC
    Prostate; 2017 Apr; 77(5):471-478. PubMed ID: 28116812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomy.
    Geybels MS; Wright JL; Bibikova M; Klotzle B; Fan JB; Zhao S; Feng Z; Ostrander EA; Lin DW; Nelson PS; Stanford JL
    Clin Epigenetics; 2016; 8():97. PubMed ID: 27651837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenome-wide DNA methylation and transcriptome profiling of localized and locally advanced prostate cancer: Uncovering new molecular markers.
    Liu Q; Reed M; Zhu H; Cheng Y; Almeida J; Fruhbeck G; Ribeiro R; Hu P
    Genomics; 2022 Sep; 114(5):110474. PubMed ID: 36057424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk score predicts high-grade prostate cancer in DNA-methylation positive, histopathologically negative biopsies.
    Van Neste L; Partin AW; Stewart GD; Epstein JI; Harrison DJ; Van Criekinge W
    Prostate; 2016 Sep; 76(12):1078-87. PubMed ID: 27121847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genome-wide analysis of DNA methylation in prostate cancer using the technology of Infinium HumanMethylation450 BeadChip (HM450)].
    Babalyan KA; Sultanov R; Generozov EV; Zakharzhevskaya NB; Sharova EI; Peshkov MN; Vasilev AO; Govorov AV; Pushkar DY; Prilepskaya EA; Danilenko SA; Babikova EA; Larin AK; Govorun VM
    Vopr Onkol; 2016; 62(1):122-32. PubMed ID: 30444590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue.
    Geybels MS; Zhao S; Wong CJ; Bibikova M; Klotzle B; Wu M; Ostrander EA; Fan JB; Feng Z; Stanford JL
    Prostate; 2015 Dec; 75(16):1941-50. PubMed ID: 26383847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Biopsy-based 17-gene Genomic Prostate Score as a Predictor of Metastases and Prostate Cancer Death in Surgically Treated Men with Clinically Localized Disease.
    Van Den Eeden SK; Lu R; Zhang N; Quesenberry CP; Shan J; Han JS; Tsiatis AC; Leimpeter AD; Lawrence HJ; Febbo PG; Presti JC
    Eur Urol; 2018 Jan; 73(1):129-138. PubMed ID: 28988753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copy number alterations are associated with metastatic-lethal progression in prostate cancer.
    Wang X; Grasso CS; Jordahl KM; Kolb S; Nyame YA; Wright JL; Ostrander EA; Troyer DA; Lance R; Feng Z; Dai JY; Stanford JL
    Prostate Cancer Prostatic Dis; 2020 Sep; 23(3):494-506. PubMed ID: 32071439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EFEMP1 as a novel DNA methylation marker for prostate cancer: array-based DNA methylation and expression profiling.
    Kim YJ; Yoon HY; Kim SK; Kim YW; Kim EJ; Kim IY; Kim WJ
    Clin Cancer Res; 2011 Jul; 17(13):4523-30. PubMed ID: 21571867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate tumor DNA methylation is associated with cigarette smoking and adverse prostate cancer outcomes.
    Shui IM; Wong CJ; Zhao S; Kolb S; Ebot EM; Geybels MS; Rubicz R; Wright JL; Lin DW; Klotzle B; Bibikova M; Fan JB; Ostrander EA; Feng Z; Stanford JL
    Cancer; 2016 Jul; 122(14):2168-77. PubMed ID: 27142338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel DNA-methylated genes that correlate with human prostate cancer and high-grade prostatic intraepithelial neoplasia.
    Devaney JM; Wang S; Funda S; Long J; Taghipour DJ; Tbaishat R; Furbert-Harris P; Ittmann M; Kwabi-Addo B
    Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):292-300. PubMed ID: 23896626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation profiling identified novel differentially methylated markers including OPCML and FLRT2 in prostate cancer.
    Wu Y; Davison J; Qu X; Morrissey C; Storer B; Brown L; Vessella R; Nelson P; Fang M
    Epigenetics; 2016 Apr; 11(4):247-58. PubMed ID: 26890304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic age signatures in bones.
    Lee HY; Hong SR; Lee JE; Hwang IK; Kim NY; Lee JM; Fleckhaus J; Jung SE; Lee YH
    Forensic Sci Int Genet; 2020 May; 46():102261. PubMed ID: 32087494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of Molecular DNA Methylation-Based Biomarkers through Genome-Wide Analysis of Response Patterns to BCG for Bladder Cancer.
    Ilijazi D; Pulverer W; Ertl IE; Lemberger U; Kimura S; Abufaraj M; D'Andrea D; Pradere B; Bruchbacher A; Graf A; Soria F; Susani M; Haitel A; Molinaro L; Pycha A; Comploj E; Pabinger S; Weinhäusel A; Egger G; Shariat SF; Hassler MR
    Cells; 2020 Aug; 9(8):. PubMed ID: 32764425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation screening of primary prostate tumors identifies SRD5A2 and CYP11A1 as candidate markers for assessing risk of biochemical recurrence.
    Horning AM; Awe JA; Wang CM; Liu J; Lai Z; Wang VY; Jadhav RR; Louie AD; Lin CL; Kroczak T; Chen Y; Jin VX; Abboud-Werner SL; Leach RJ; Hernandez J; Thompson IM; Saranchuk J; Drachenberg D; Chen CL; Mai S; Huang TH
    Prostate; 2015 Nov; 75(15):1790-801. PubMed ID: 26332453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChips.
    Naumov VA; Generozov EV; Zaharjevskaya NB; Matushkina DS; Larin AK; Chernyshov SV; Alekseev MV; Shelygin YA; Govorun VM
    Epigenetics; 2013 Sep; 8(9):921-34. PubMed ID: 23867710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternations of gene expression in PI3K and AR pathways and DNA methylation features contribute to metastasis of prostate cancer.
    Zhao Y; Hu X; Yu H; Liu X; Sun H; Shao C
    Cell Mol Life Sci; 2022 Jul; 79(8):436. PubMed ID: 35864178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.